DRS vs IDXX · P/E 43, rev $1.76B vs P/E 40, rev $2.36B
Leonardo DRS, Inc. Common Stock (DRS) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Leonardo DRS, Inc. Common Stock (DRS) is a aerospace & defense company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported DRS revenue for 2026-06-30 was $1.76B. Net income was $148.0M. DRS currently screens at market cap $12.31B and trailing P/E 43.1.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
DRS currently screens at market cap $12.31B and trailing P/E 43.1. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the DRS and IDXX stock pages for the full models.
Not investment advice.